Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Account Payables: 2018-2024

Historic Change in Account Payables for ADC Therapeutics (ADCT) over the last 7 years, with Dec 2024 value amounting to $2.5 million.

  • ADC Therapeutics' Change in Account Payables rose 2016.87% to $6.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.2 million, marking a year-over-year increase of 923.55%. This contributed to the annual value of $2.5 million for FY2024, which is 22.41% down from last year.
  • ADC Therapeutics' Change in Account Payables amounted to $2.5 million in FY2024, which was down 22.41% from $3.2 million recorded in FY2023.
  • Over the past 5 years, ADC Therapeutics' Change in Account Payables peaked at $6.8 million during FY2021, and registered a low of $310,000 during FY2022.
  • Over the past 3 years, ADC Therapeutics' median Change in Account Payables value was $2.5 million (recorded in 2024), while the average stood at $2.0 million.
  • In the last 5 years, ADC Therapeutics' Change in Account Payables crashed by 95.44% in 2022 and then spiked by 923.55% in 2023.
  • Over the past 5 years, ADC Therapeutics' Change in Account Payables (Yearly) stood at $1.9 million in 2020, then surged by 253.88% to $6.8 million in 2021, then tumbled by 95.44% to $310,000 in 2022, then soared by 923.55% to $3.2 million in 2023, then declined by 22.41% to $2.5 million in 2024.